ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $235,000 | -65.2% | 2,002 | -60.1% | 0.01% | -66.7% |
| Q4 2021 | $675,000 | -69.4% | 5,019 | -70.1% | 0.02% | -69.4% |
| Q2 2021 | $2,209,000 | +145.4% | 16,793 | +140.4% | 0.05% | +145.0% |
| Q1 2021 | $900,000 | -10.4% | 6,984 | +16.1% | 0.02% | +5.3% |
| Q4 2020 | $1,004,000 | -36.0% | 6,018 | -40.8% | 0.02% | -54.8% |
| Q3 2020 | $1,568,000 | +5.5% | 10,163 | +1.1% | 0.04% | -2.3% |
| Q2 2020 | $1,486,000 | +174.2% | 10,049 | +108.7% | 0.04% | +104.8% |
| Q1 2020 | $542,000 | -22.1% | 4,815 | -3.7% | 0.02% | +90.9% |
| Q4 2019 | $696,000 | +82.2% | 5,000 | -77.3% | 0.01% | -35.3% |
| Q1 2015 | $382,000 | – | 22,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |